Cite
HARVARD Citation
Argyriou, A. et al. (2021). Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders. Expert review of neurotherapeutics. pp. 923-944. [Online].